Accelerating the pathway from drug discovery to patient treatment – pioneering advanced development methodologies for new TB drug regimens.Read More..
Empowering African clinical trial sites through tailored local monitoring programmes.Read More..
Developing limitless collaboration opportunities – academia, enterprises, governments, foundations, patient groups – a unique platform provided through a non-commercial broker!Read More..
We are faced with a global pandemic of tuberculosis and new tools to control this disease are needed urgently. We believe that new drugs are central to any control strategy and the fastest route to tuberculosis elimination.
The consortium brings together a group of scientists from more that 14 countries with skills in clinical trials, pulmonology, mycobacteriology, pharmacokinetics, statistics and delivery of clinical service.
PanACEA’s MAMS study continues to enroll patients rapidly. By mid-October more than 200 of the required 372 patients have been enrolled. Recruitment is thus ahead of...
The 5th Annual PanACEA Meeting has been held on Ile de Gorée / Dakar, Senegal from 19-21 Oct 2013, just preceeding the 7th EDCTP Forum. Inspite of a couple of...